Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Katrin Oertel(Jena University Hospital), Orlando Guntinas‐Lichius(Jena University Hospital), Harald Schmalenberg(Heidelberg University), Thomas Kuhnt(Leipzig University), Georg Maschmeyer(Radboud University Medical Center), Karin Spiegel(Jena University Hospital), Thomas Wendt(Universität Trier), Andreas Dietz(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Holger Sudhoff(Bielefeld University)
BMC Cancer
October 20, 2012
Cited by 14


Related Papers